Publications by authors named "Ken Zaner"

Claim this Profile
A
Assessing cumulative acute toxicity of chemoradiotherapy in head and neck cancer with or without induction chemotherapy.
Bhartesh A Shah, Muhammad M Qureshi, Jennifer M Logue, Timothy P Cooley, Ken S Zaner

Am J Otolaryngol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of decision making at a multidisciplinary head and neck tumor board incorporating evidence-based National Cancer Comprehensive Network (NCCN) guidelines.
Bhartesh A Shah, Muhammad M Qureshi, Scharukh Jalisi, Gregory Grillone, Andrew Salama, Ken Zaner

Pract Radiat Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of limited English proficiency on outcome in patients treated with radiotherapy for head and neck cancer.
Muhammad M Qureshi, Paul B Romesser, Scharukh Jalisi, Ken S Zaner, Timothy P Cooley

Patient Educ Couns· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health behaviors, readiness to change, and interest in health promotion programs among smokers with lung cancer and their family members: a pilot study.
Mary E Cooley, Kathleen T Finn, Qian Wang, Kristin Roper, Sandra Morones, Ken Zaner

Cancer Nurs· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Creating computable algorithms for symptom management in an outpatient thoracic oncology setting.
Mary E Cooley, David F Lobach, Ellis Johns, Barbara Halpenny, Toni-Ann Saunders, Ken Zaner

J Pain Symptom Manage· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node-negative T3 and T4 non-small cell lung cancer.
Benedict D T Daly, Michael I Ebright, Allan J Walkey, Hiran C Fernando, Ken S Zaner

J Thorac Cardiovasc Surg· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer.
Akash Nanda, Dora C Dias-Santagata, Hannah Stubbs, Carl J O'Hara, Ken S Zaner

Clin Lung Cancer· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative radiation therapy of symptomatic recurrent bladder cancer.
Sun K Yi, Mark Yoder, Ken Zaner, Ariel E Hirsch

Pain Physician· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.
Tomislav Dragovich, Sheryl McCoy, Cecilia M Fenoglio-Preiser, Jiang Wang, Jacqueline K Benedetti, Ken S Zaner

J Clin Oncol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancer.
Wallace Akerley, Howard Safran, Ken Zaner, Neal Ready, Tony Mega

Cancer· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis